🚀 VC round data is live in beta, check it out!
Eurofins Scientific Valuation Multiples
Discover revenue and EBITDA valuation multiples for Eurofins Scientific and similar public comparables like Medpace, bioMérieux, Divi's Laboratories, Max Healthcare Institute and more.
Eurofins Scientific Overview
About Eurofins Scientific
Eurofins, headquartered in Luxembourg, is a decentralized network of life sciences companies that provide various analytical tests and laboratory services. These include tests to evaluate the safety, identity, composition, authenticity, purity, origin, and traceability of various biological substances and products. Eurofins operates over 950 laboratories in 61 countries. Its revenue from Europe, North America, and the rest of the world contributes approximately 50%, 40%, and 10% of total revenue, respectively. Its areas of business activity are food, feed, and environmental testing ("life"), biopharmaceutical services, diagnostic services and products, and consumer and technology products testing, which contribute approximately 40%, 30%, 20%, and 10% respectively.
Founded
1987
HQ
Employees
62.7K
Website
Financials (LTM)
EV
$19B
Eurofins Scientific Financials
Eurofins Scientific reported last 12-month revenue of $9B and EBITDA of $2B.
In the same LTM period, Eurofins Scientific generated $2B in EBITDA and $620M in net income.
Revenue (LTM)
Eurofins Scientific P&L
In the most recent fiscal year, Eurofins Scientific reported revenue of $9B and EBITDA of $2B.
Eurofins Scientific expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $9B | XXX | $9B | XXX | XXX | XXX |
| Gross Profit | — | XXX | $6B | XXX | XXX | XXX |
| Gross Margin | — | XXX | 67% | XXX | XXX | XXX |
| EBITDA | $2B | XXX | $2B | XXX | XXX | XXX |
| EBITDA Margin | 23% | XXX | 22% | XXX | XXX | XXX |
| EBIT Margin | 14% | XXX | 14% | XXX | XXX | XXX |
| Net Profit | $620M | XXX | $564M | XXX | XXX | XXX |
| Net Margin | 7% | XXX | 6% | XXX | XXX | XXX |
| Net Debt | — | — | $4B | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Eurofins Scientific Stock Performance
Eurofins Scientific has current market cap of $14B, and enterprise value of $19B.
Market Cap Evolution
Eurofins Scientific's stock price is $82.00.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $19B | $14B | -0.3% | XXX | XXX | XXX | $3.22 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialEurofins Scientific Valuation Multiples
Eurofins Scientific trades at 2.1x EV/Revenue multiple, and 9.4x EV/EBITDA.
EV / Revenue (LTM)
Eurofins Scientific Financial Valuation Multiples
As of April 21, 2026, Eurofins Scientific has market cap of $14B and EV of $19B.
Equity research analysts estimate Eurofins Scientific's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Eurofins Scientific has a P/E ratio of 23.2x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $14B | XXX | $14B | XXX | XXX | XXX |
| EV (current) | $19B | XXX | $19B | XXX | XXX | XXX |
| EV/Revenue | 2.1x | XXX | 2.1x | XXX | XXX | XXX |
| EV/EBITDA | 9.4x | XXX | 9.5x | XXX | XXX | XXX |
| EV/EBIT | 15.1x | XXX | 15.5x | XXX | XXX | XXX |
| EV/Gross Profit | — | XXX | 3.2x | XXX | XXX | XXX |
| P/E | 23.2x | XXX | 25.4x | XXX | XXX | XXX |
| EV/FCF | 19.0x | XXX | 17.8x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Eurofins Scientific Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Eurofins Scientific Margins & Growth Rates
Eurofins Scientific's revenue in the last 12 month grew by 5%.
Eurofins Scientific's revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $0.1M for the same period.
Eurofins Scientific's rule of 40 is 28% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Eurofins Scientific's rule of X is 36% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Eurofins Scientific Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 5% | XXX | 4% | XXX | XXX | XXX |
| EBITDA Margin | 23% | XXX | 22% | XXX | XXX | XXX |
| EBITDA Growth | 6% | XXX | 4% | XXX | XXX | XXX |
| Rule of 40 | — | XXX | 28% | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | 36% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.1M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.1M | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 56% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Eurofins Scientific Public Comps
See public comps and valuation multiples for other Laboratory Services and Contract Research & Manufacturing comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Eurofins Scientific | XXX | XXX | XXX | XXX | XXX | XXX |
| Medpace | XXX | XXX | XXX | XXX | XXX | XXX |
| bioMérieux | XXX | XXX | XXX | XXX | XXX | XXX |
| Divi's Laboratories | XXX | XXX | XXX | XXX | XXX | XXX |
| Max Healthcare Institute | XXX | XXX | XXX | XXX | XXX | XXX |
| Revvity | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Eurofins Scientific M&A Activity
Eurofins Scientific acquired XXX companies to date.
Last acquisition by Eurofins Scientific was on XXXXXXXX, XXXXX. Eurofins Scientific acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Eurofins Scientific
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialEurofins Scientific Investment Activity
Eurofins Scientific invested in XXX companies to date.
Eurofins Scientific made its latest investment on XXXXXXXX, XXXXX. Eurofins Scientific invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Eurofins Scientific
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Eurofins Scientific
| When was Eurofins Scientific founded? | Eurofins Scientific was founded in 1987. |
| Where is Eurofins Scientific headquartered? | Eurofins Scientific is headquartered in Luxembourg. |
| How many employees does Eurofins Scientific have? | As of today, Eurofins Scientific has over 62K employees. |
| Who is the CEO of Eurofins Scientific? | Eurofins Scientific's CEO is Gilles G. Martin. |
| Is Eurofins Scientific publicly listed? | Yes, Eurofins Scientific is a public company listed on Euronext Paris. |
| What is the stock symbol of Eurofins Scientific? | Eurofins Scientific trades under ERF ticker. |
| When did Eurofins Scientific go public? | Eurofins Scientific went public in 1997. |
| Who are competitors of Eurofins Scientific? | Eurofins Scientific main competitors are Medpace, bioMérieux, Divi's Laboratories, Max Healthcare Institute. |
| What is the current market cap of Eurofins Scientific? | Eurofins Scientific's current market cap is $14B. |
| What is the current revenue of Eurofins Scientific? | Eurofins Scientific's last 12 months revenue is $9B. |
| What is the current revenue growth of Eurofins Scientific? | Eurofins Scientific revenue growth (NTM/LTM) is 5%. |
| What is the current EV/Revenue multiple of Eurofins Scientific? | Current revenue multiple of Eurofins Scientific is 2.1x. |
| Is Eurofins Scientific profitable? | Yes, Eurofins Scientific is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Eurofins Scientific? | Eurofins Scientific's last 12 months EBITDA is $2B. |
| What is Eurofins Scientific's EBITDA margin? | Eurofins Scientific's last 12 months EBITDA margin is 23%. |
| What is the current EV/EBITDA multiple of Eurofins Scientific? | Current EBITDA multiple of Eurofins Scientific is 9.4x. |
| What is the current FCF of Eurofins Scientific? | Eurofins Scientific's last 12 months FCF is $981M. |
| What is Eurofins Scientific's FCF margin? | Eurofins Scientific's last 12 months FCF margin is 11%. |
| What is the current EV/FCF multiple of Eurofins Scientific? | Current FCF multiple of Eurofins Scientific is 19.0x. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.